Stay updated on Nivolumab and Ipilimumab Combination Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Ipilimumab Combination Clinical Trial page.

Latest updates to the Nivolumab and Ipilimumab Combination Clinical Trial page
- Check7 days agoChange DetectedAdded Melanoma to related topics and MedlinePlus Genetics as a related topic; these are navigational aids and do not modify trial information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check14 days agoChange DetectedSite revision updated to v3.3.2; Melanoma topic and MedlinePlus Genetics related topics, along with the v3.3.1 revision entry, were removed from the page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedThe Publications section now notes that entries are automatically filled from PubMed and adds Revision: v3.3.1; the previous PubMed description and older revision label were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedThe government funding/operating status notice has been removed; core trial details, such as interventions, eligibility, and locations, remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check43 days agoChange DetectedThe two screenshots show no changes to core study content such as title, conditions, interventions, outcomes, or enrollment; only minor visual or layout adjustments are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check57 days agoChange DetectedRemoved a MedlinePlus Genetics topic: Melanoma. This reduces coverage of the genetics-related content on melanoma.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Ipilimumab Combination Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Ipilimumab Combination Clinical Trial page.